Demystifying Adient: Insights From 8 Analyst Reviews
In the preceding three months, 8 analysts have released ratings for Adient (NYSE:ADNT), presenting a wide array of perspectives from bullish to bearish.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 3 | 1 | 4 | 0 | 0 |
| Last 30D | 1 | 0 | 1 | 0 | 0 |
| 1M Ago | 2 | 1 | 1 | 0 | 0 |
| 2M Ago | 0 | 0 | 1 | 0 | 0 |
| 3M Ago | 0 | 0 | 1 | 0 | 0 |
Analysts have recently evaluated Adient and provided 12-month price targets. The average target is $25.81, accompanied by a high estimate of $32.00 and a low estimate of $20.00. Marking an increase of 8.67%, the current average surpasses the previous average price target of $23.75.
Investigating Analyst Ratings: An Elaborate Study
The standing of Adient among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Joseph Spak | UBS | Raises | Buy | $32.00 | $30.00 |
| Andrew Percoco | Morgan Stanley | Raises | Equal-Weight | $22.00 | $20.00 |
| Nathan Janes | Stifel | Raises | Buy | $26.00 | $24.00 |
| Dan Levy | Barclays | Raises | Equal-Weight | $25.00 | $24.00 |
| Joseph Spak | UBS | Raises | Buy | $30.00 | $22.00 |
| Colin Langan | Wells Fargo | Raises | Overweight | $29.00 | $28.00 |
| Andrew Percoco | Morgan Stanley | Raises | Equal-Weight | $20.00 | $17.00 |
| Michael Ward | Citigroup | Lowers | Neutral | $22.50 | $25.00 |
Key Insights:
- Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Adient. This information provides a snapshot of how analysts perceive the current state of the company.
- Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Adient compared to the broader market.
- Price Targets: Analysts provide insights into price targets, offering estimates for the future value of Adient's stock. This comparison reveals trends in analysts' expectations over time.
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Adient's market position. Stay informed and make well-informed decisions with our Ratings Table.
Stay up to date on Adient analyst ratings.
If you are interested in following small-cap stock news and performance you can start by tracking it here.
All You Need to Know About Adient
Adient began trading Oct. 31, 2016, when Johnson Controls spun off its automotive experience segment. Adient is a leading seating supplier to the industry with about a midteens share of the global market including unconsolidated joint venture business. Its share in China is around 20%, down from about 45%, following the sale of its main joint venture there at the end of fiscal 2021. Unconsolidated revenue from joint ventures was about $3.5 billion in fiscal 2025 and consolidated China revenue was $1.3 billion. The company is headquartered in Ireland but has corporate offices in the Detroit area. Fiscal 2025 (Sept. 30 year-end) consolidated revenue, which excludes joint venture sales, was $14.5 billion.
Adient's Financial Performance
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
Revenue Growth: Over the 3M period, Adient showcased positive performance, achieving a revenue growth rate of 3.54% as of 30 September, 2025. This reflects a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Consumer Discretionary sector.
Net Margin: Adient's net margin is impressive, surpassing industry averages. With a net margin of 0.49%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Adient's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of 1.01%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): Adient's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of 0.2%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: Adient's debt-to-equity ratio surpasses industry norms, standing at 1.36. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
Understanding the Relevance of Analyst Ratings
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
This article was generated by Benzinga's automated content engine and reviewed by an editor.